74 results
8-K
EX-10.2
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts
8-K
EX-10.4
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as management of the Company
8-K
EX-10.6
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
.
v. Insurance. The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks
8-K
EX-10.1
t9cjcans0s igu
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.4
fro8 lpm4
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
y3sp5
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
nzuy4x8ey9z7vnbm
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.4
w33l8osf
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm